1,118
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Hyperammonemia in the setting of Roux-en-Y gastric bypass presenting with osmotic demyelination syndrome

&
Pages 708-712 | Received 19 May 2021, Accepted 01 Jul 2021, Published online: 20 Sep 2021

References

  • Nagarur A, Fenves AZ. Late presentation of fatal hyperammonemic encephalopathy after Roux-en-Y gastric bypass. Proc (Bayl Univ Med Cent). 2017 Jan;30(1):41–43.
  • Kofman BM, Greenfeld LJ, Ali II, et al. Neurologic complications after surgery for obesity. Muscle Nerve. 2006;33(2):166–176.
  • Kromas ML, Mousa OY, John S. Hyperammonemia-induced encephalopathy: a rare devastating complication of bariatric surgery. World J Hepatol. 2015 May 8;7(7):1007–1011.
  • Salcedo JD, Goldstein JS, Quinonez JM, et al. Nonfatal hyperammonemic encephalopathy as a late complication of Roux-en-Y gastric bypass. Case Rep Gastrointest Med. 2019;2019:9031087.
  • Langer JE, Wilson WG, Raghavan P, et al. Extrapontine myelinosis resulting in transient cortical blindness. Pediatr Neurol. 2010 Feb 1;42(2):154–156.
  • Mattson LR, Lindor NM, Goldman DH, et al. Central pontine myelinolysis as a complication of partial ornithine carbamoyl transferase deficiency. Am J Med Genet. 1995 June 19;60(3):210–213.
  • Scott TR, Kronsten VT, Hughes RD, et al. Pathophysiology of cerebral oedema in acute liver failure. World J Gastroenterol. 2013 Dec 28;19(48):9240–9255.
  • Rao KVR, Jayakumar AR, Norenberg MD. Induction of the mitochondrial permeability transition in cultured astrocytes by glutamine. Neurochem Int. 2003 Sept–Oct;43(4–5):517–523.
  • Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology. 2006;44:788–794.
  • Yuridullah R, Kumar V, Nanavati S, et al. Clinical resolution of osmotic demyelination syndrome following overcorrection of severe hyponatremia. Case Rep Nephrol. 2019;2019:Article ID 1757656, 4 pages.
  • Gupta S, Fenves AZ, Hootkins R. The role of RRT in hyperammonemic patients. Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1872–1878.
  • Alimirah M, Sadiq O, Gordon SC. Novel therapies in hepatic encephlopathy. Clin Liver Dis. 2020 May;24(2):303–315.
  • Jalan R, Wright G, Davies NA, et al. L-ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy. Med Hypotheses. 2007;69(5):1064–1069.